Standard BioTools Inc.
Standard BioTools Inc.（LAB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · LAB · 截至 2026年6月8日
活动摘要
买入笔数
24
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Standard BioTools Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
LAB 季度内部人买卖趋势
LAB 内幕交易卖出 · LAB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · LAB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
LAB 高管卖出股份 · LAB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 20, 2026 | Kim Hanjoon Alex CFO | Other | 18,871 | $19K | Form 4 |
| May 20, 2026 | Mackay Sean SVP & Chief Business Officer | Other | 25,729 | $26K | Form 4 |
| May 20, 2026 | Egholm Michael President & CEO · Director | Other | 97,626 | $98K | Form 4 |
| Apr 6, 2026 | Egholm Michael President & CEO · Director | Option | 196,513 | — | Form 4 |
| Apr 6, 2026 | Egholm Michael President & CEO · Director | Other | 95,014 | $86K | Form 4 |
| Mar 20, 2026 | Egholm Michael President & CEO · Director | Award | 1,042,373 | — | Form 4 |
| Mar 20, 2026 | Mackay Sean SVP & Chief Business Officer | Award | 272,107 | — | Form 4 |
| Apr 6, 2026 | Kim Hanjoon Alex CFO | Option | 70,183 | — | Form 4 |
| Apr 6, 2026 | Kim Hanjoon Alex CFO | Other | 21,301 | $19K | Form 4 |
| Mar 20, 2026 | Kim Hanjoon Alex CFO | Award | 323,173 | — | Form 4 |
| Feb 26, 2026 | Casdin Eli Director | Award | 52,991 | $62K | Form 4 |
| Feb 26, 2026 | Cox Troy Director | Award | 57,264 | $67K | Form 4 |
| Feb 26, 2026 | Carey Thomas D. Director | Award | 51,282 | $60K | Form 4 |
| Feb 23, 2026 | Egholm Michael President & CEO · Director | Other | 66,127 | $76K | Form 4 |
| Feb 23, 2026 | Mackay Sean SVP & Chief Business Officer | Other | 19,661 | $23K | Form 4 |
| Feb 23, 2026 | Kim Hanjoon Alex CFO | Other | 12,740 | $15K | Form 4 |
| Nov 20, 2025 | Egholm Michael President & CEO · Director | Other | 63,529 | $81K | Form 4 |
| Nov 20, 2025 | Kim Hanjoon Alex CFO | Other | 12,739 | $16K | Form 4 |
| Nov 20, 2025 | Mackay Sean SVP & Chief Business Officer | Other | 19,661 | $25K | Form 4 |
| Aug 20, 2025 | Egholm Michael President & CEO · Director | Other | 54,919 | $70K | Form 4 |
| Aug 20, 2025 | Mackay Sean SVP & Chief Business Officer | Other | 19,661 | $25K | Form 4 |
| Aug 20, 2025 | Kim Hanjoon Alex CFO | Other | 12,739 | $16K | Form 4 |
| Aug 15, 2025 | Casdin Partners Master Fund, L.P. Director | Purchase | 150,000 | $183K | Form 4 |
| Aug 14, 2025 | Casdin Partners Master Fund, L.P. Director | Purchase | 133,220 | $162K | Form 4 |
| Aug 13, 2025 | Casdin Partners Master Fund, L.P. Director | Purchase | 75,000 | $98K | Form 4 |
Casdin Partners Master Fund, L.P.
Director
日期
Aug 15
股数
150,000
均价
$1.22
总金额
$183K
Casdin Partners Master Fund, L.P.
Director
日期
Aug 14
股数
133,220
均价
$1.21
总金额
$162K
Casdin Partners Master Fund, L.P.
Director
日期
Aug 13
股数
75,000
均价
$1.31
总金额
$98K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 LAB 内幕交易
LAB 内幕交易
Standard BioTools Inc.（LAB）内幕交易数据来源于公司内部人（包括Kim Hanjoon Alex (CFO), Egholm Michael (President & CEO · Director), Mackay Sean (SVP & Chief Business Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。LAB内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Standard BioTools Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
LAB 内幕交易 · 5个问题Standard BioTools Inc.（LAB）的内部人包括高管和董事，如Kim Hanjoon Alex (CFO), Egholm Michael (President & CEO · Director), Mackay Sean (SVP & Chief Business Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026